Genomics of Premature Atherosclerotic Vascular Disease

David M Seo, Pascal Goldschmidt-Clermont, Omaida C Velazquez, Gary W Beecham

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Atherosclerotic vascular disease is a systemic process with a common pathophysiology but with different disease manifestations depending on the vascular site. Over the past two decades, significant efforts have gone toward determining the genomic factors contributing to atherosclerotic vascular disease. Substantial information has been generated regarding the genomics of atherosclerotic coronary heart disease, and recently, several genomic analyses have looked at the cerebrovascular and peripheral vascular beds. This article reviews genomic investigations of atherosclerotic vascular disease in the coronary, cerebrovascular, and peripheral arteries. In this review, we have tried to restrict the discussion to studies of premature atherosclerosis, particularly those using non-biased genomic techniques.

Original languageEnglish
Pages (from-to)187-193
Number of pages7
JournalCurrent Atherosclerosis Reports
Volume12
Issue number3
DOIs
StatePublished - May 1 2010

Fingerprint

Genomics
Vascular Diseases
Blood Vessels
Coronary Disease
Atherosclerosis
Arteries

Keywords

  • Atherosclerosis
  • Cerebrovascular disease
  • Coronary artery disease
  • Genomics
  • Peripheral vascular disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Genomics of Premature Atherosclerotic Vascular Disease. / Seo, David M; Goldschmidt-Clermont, Pascal; Velazquez, Omaida C; Beecham, Gary W.

In: Current Atherosclerosis Reports, Vol. 12, No. 3, 01.05.2010, p. 187-193.

Research output: Contribution to journalArticle

@article{38f3b0fe007b4ff1a0057a0f5716a88c,
title = "Genomics of Premature Atherosclerotic Vascular Disease",
abstract = "Atherosclerotic vascular disease is a systemic process with a common pathophysiology but with different disease manifestations depending on the vascular site. Over the past two decades, significant efforts have gone toward determining the genomic factors contributing to atherosclerotic vascular disease. Substantial information has been generated regarding the genomics of atherosclerotic coronary heart disease, and recently, several genomic analyses have looked at the cerebrovascular and peripheral vascular beds. This article reviews genomic investigations of atherosclerotic vascular disease in the coronary, cerebrovascular, and peripheral arteries. In this review, we have tried to restrict the discussion to studies of premature atherosclerosis, particularly those using non-biased genomic techniques.",
keywords = "Atherosclerosis, Cerebrovascular disease, Coronary artery disease, Genomics, Peripheral vascular disease",
author = "Seo, {David M} and Pascal Goldschmidt-Clermont and Velazquez, {Omaida C} and Beecham, {Gary W}",
year = "2010",
month = "5",
day = "1",
doi = "10.1007/s11883-010-0104-9",
language = "English",
volume = "12",
pages = "187--193",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Genomics of Premature Atherosclerotic Vascular Disease

AU - Seo, David M

AU - Goldschmidt-Clermont, Pascal

AU - Velazquez, Omaida C

AU - Beecham, Gary W

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Atherosclerotic vascular disease is a systemic process with a common pathophysiology but with different disease manifestations depending on the vascular site. Over the past two decades, significant efforts have gone toward determining the genomic factors contributing to atherosclerotic vascular disease. Substantial information has been generated regarding the genomics of atherosclerotic coronary heart disease, and recently, several genomic analyses have looked at the cerebrovascular and peripheral vascular beds. This article reviews genomic investigations of atherosclerotic vascular disease in the coronary, cerebrovascular, and peripheral arteries. In this review, we have tried to restrict the discussion to studies of premature atherosclerosis, particularly those using non-biased genomic techniques.

AB - Atherosclerotic vascular disease is a systemic process with a common pathophysiology but with different disease manifestations depending on the vascular site. Over the past two decades, significant efforts have gone toward determining the genomic factors contributing to atherosclerotic vascular disease. Substantial information has been generated regarding the genomics of atherosclerotic coronary heart disease, and recently, several genomic analyses have looked at the cerebrovascular and peripheral vascular beds. This article reviews genomic investigations of atherosclerotic vascular disease in the coronary, cerebrovascular, and peripheral arteries. In this review, we have tried to restrict the discussion to studies of premature atherosclerosis, particularly those using non-biased genomic techniques.

KW - Atherosclerosis

KW - Cerebrovascular disease

KW - Coronary artery disease

KW - Genomics

KW - Peripheral vascular disease

UR - http://www.scopus.com/inward/record.url?scp=77953620696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953620696&partnerID=8YFLogxK

U2 - 10.1007/s11883-010-0104-9

DO - 10.1007/s11883-010-0104-9

M3 - Article

C2 - 20425258

AN - SCOPUS:77953620696

VL - 12

SP - 187

EP - 193

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 3

ER -